In vitro evaluation of intracellular activity of antibiotics against non-typhoid Salmonella

International Journal of Antimicrobial Agents

Volumn 12, Issue 1, 1999, Pages 47-52

  Chiu, Cheng Hsun ^a,b   Lin, Tzou Yien ^a   Ou, Jonathan T ^a  

^a Dept Med Chang Gung Children's H   (Taiwan)

^b British Columbia Research Institute   (Canada)

Author keywords

Antibiotics; Non typhoid salmonellae

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; GENTAMICIN; OFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOSTASIS; CONTROLLED STUDY; ENTERITIS; HUMAN; IN VITRO STUDY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SALMONELLA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; COLONY COUNT, MICROBIAL; ENTERITIS; HUMANS; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 0032972628     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00038-2     Document Type: Article

References (23)

1. Kazemi M., Gumpert T.G., Marks M.I. A controlled trial comparing sulfamethoxazole-trimethoprim, ampicillin and no therapy in the treatment of salmonella gastroenteritis in children. J. Pediatr. 83:1973;646-650.
2. Garcia de Olarte D., Trujillo H., Agudelo N., Nelson J.D., Haltalin K.C. Treatment of diarrhea in malnourished infants and childen. Am. J. Dis. Child. 127:1974;379-388.
3. Nelson J.D., Kusmiesz H., Jackson L.H., Woodman E. Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics. 65:1980;1125-1130.
4. Soe G.B., Overturf G.D. Treatment of typhoid fever and other systemic salmonellosis with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev. Infect. Dis. 9:1987;719-736.
5. Hooper D.C., Wolfson J.S. The fluoroquinolones: pharmacology, clinical use, and toxicities in humans. Antimicrob. Agents Chemother. 28:1985;716-721.
6. Rakita R.M., Jacques-Palaz K., Murray B.E. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob. Agents Chemother. 38:1994;1915-1921.
7. Gladue R.P., Bright G.M., Isaacson R.E., Newborg M.F. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:1989;277-282.
8. Ou J.T., Baron L.S. Strain differences in expression of virulence by the 90 kb virulence plasmid of Salmonella serovar Typhimurium. Microb. Pathog. 10:1991;247-251.
9. Cohen J.I., Bartlett J.A., Corey R. Extra-intestinal manifestations of Salmonella infections. Medicine. 66:1987;349-388.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved Standard. National Committee for Clinical Laboratory Standards. Villanova, PA, 1993.
11. Hand W.L., King-Thompson N.L. Contrasts between phagocytic antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob. Agents Chemother. 29:1986;135-140.
12. Prokesch R.C., Hand W.L. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 21:1982;373-380.
13. Maurin M., Raoult D. Intracellular organisms. Int. J. Antimicrob. Agents. 9:1997;61-70.
14. Anton P.A., Kemp J.A., Butler T., Jacobs M.R. Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection. Antimicrob. Agents Chemother. 22:1982;312-315.
15. Milatovic E. Intraphagocytic activity of erythromycin, roxithromycin and azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 1:1990;33-35.
16. Herrera-Insua I., Jacques-Palaz K., Murray B.E., Rakita R.M. Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium. Antimicrob. Agents Chemother. 40:1996;886-890.
17. Jacques Y.V., Bainton D.F. Changes in pH within the phagocytic vacuoles of human neutrophils and monocytes. Lab. Invest. 39:1978;179-185.
18. Tulkens P.M. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand. J. Infect. Dis. 74:1991;209-217.
19. Drancourt M., Raoult D. Methodology of antibiotics testing for intracellular pathogens. Raoult D. Antimicrobial Agents and Intracellular Pathogens. 5th edition:1993;71-85 CRC Press, Boca Raton, FL.
20. Pichler H.E.T., Diridl G., Sticler K., Wolf D. Clinical efficacy of ciproploxacin compared with placebo in bacterial diarrhea. Am. J. Med. 82(Suppl. 4A):1987;329-332.
21. Winstrom J., Jertborn M., Ekwall E. et al. Empiric treatment of acute diarrhea disease with norfloxacin. Ann. Intern. Med. 117:1992;202-208.
22. Sanchez C., Garcia-Restoy E., Garau J. et al. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. J. Infect. Dis. 168:1993;1304-1307.
23. Tribble D.R., Cirgis N., Habib N.F., Butler T. Efficacy of azithromycin for typhoid fever. Clin. Infect. Dis. 21:1995;1045-1046.